Relier Pairs Diabetes Oral MedsVersion en ligne NUr115 Oral Diabetic Agents par Concetta Fiorentino 1 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. 2 Prevents kidneys from reabsorbing glucose. 3 Drug to drug interaction with NSAIDS. 4 Stimulate beta cells of the pancreas. 5 Usually given once a day. 6 Inhibit production of glucose by the liver. 7 Do not increased insulin secretion. 8 Stimulate pancreas to secrete insulin. 9 Sensitize body tissue to insulin: stimulates insulin receptor sites. 10 Possible side-effect of impaired platelet function. 11 Enhances glucose-dependent insulin secretion. glipizide Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl) Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix) Januvia Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Avandia Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance) Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus)
Créer jeu